Work

Phase III trial of high-dose interferon alpha-2b versus cisplatin, vinblastine, DTIC plus IL-2 and interferon in patients with high-risk melanoma (SWOG S0008): An intergroup study of CALGB, COG, ECOG, and SWOG.

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.8504

Authors: Lawrence E. Flaherty, James Moon, Michael B. Atkins, Ralph Tuthill, John A. Thompson, John T. Vetto, Frank G. Haluska, Alberto S. Pappo, Jeffrey Alan Sosman, Bruce G. Redman, Antoni Ribas, John M. Kirkwood, Vernon K. Sondak

Institutions: Wayne State University, SWOG Cancer Research Network, Beth Israel Deaconess Medical Center, Cleveland Clinic, Seattle Cancer Care Alliance, Oregon Health & Science University, ARIAD Pharmaceuticals (United States), St. Jude Children's Research Hospital, Vanderbilt University Medical Center, University of Michigan, University of California, Los Angeles, UPMC Hillman Cancer Center, Moffitt Cancer Center

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2229776725

Cites: 30

Cited by: 22

Related to: 10